Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 185 (5) , 1180-1185
- https://doi.org/10.1067/mob.2001.117669
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trialMaturitas, 1998
- Effects of a new estrogen/progestin combination in the treatment of postmenopausal syndromeMaturitas, 1995
- Cyclic-combined Conjugated Estrogens and Dydrogesterone in the Treatment of Postmenopausal SyndromeMenopause, 1995
- Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: Effects on bone mineral density and metabolismMaturitas, 1994
- Bone loss in perimenopausal women: a longitudinal studyMaturitas, 1994
- Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosisThe American Journal of Medicine, 1993
- The pathophysiology of peri‐ and postmenopausal bone lossBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Estrogen therapy in the prevention and management of osteoporosisAmerican Journal of Obstetrics and Gynecology, 1987
- Long-Term Estrogen Replacement Therapy Prevents Bone Loss and FracturesAnnals of Internal Medicine, 1985